Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
批准号:
10161123
负责人:
Donald Richieri Griffin
金额:
$14.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2021-06-30
关键词:
AddressAmino Acid SubstitutionAmino AcidsBiocompatible MaterialsBrainCaliberCell LineCellsCharacteristicsCrosslinkerDataDermalDiabetic mouseEngineeringEnsureExperimental DesignsExposure toFormulationFundingGelGenerationsGeometryGoalsGrowthHeparinHistologyHydrogelsImmuneImmune responseImmunofluorescence ImmunologicIn SituIn VitroIndividualInflammationInjectableInstructionInterstitial CollagenaseInvestigationIslandLibrariesMaintenanceMediatingMicrofluidicsMicroscopicNanoporousNatural regenerationPeptide HydrolasesPeptidesPhysiologicalPorosityPropertyProteolysisPublishingRegenerative responseResearch ProposalsResistanceResolutionSkinSplint DeviceTestingThickTimeTimeLineTissuesWound modelsangiogenesisbasecollagenase 1designdiabeticdiabetic ulcerdiabetic wound healingexperimental studyhealingimmunoregulationimprovedin vivokeratinocytemacrophagemigrationneurogenesisnon-diabeticnovelparticleprematureprotein aminoacid sequenceresponsescaffoldtranslational impactwoundwound closurewound environmentwound healingwound treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
In this proposal, we aim to engineer a biomaterial scaffold to accelerate diabetic wound closure by improving upon a
new sub-class of hydrogel biomaterials we have invented called Microporous Annealed Particle gel or MAP gel. MAP
gels are composed of microscopic spherical building blocks made using microfluidic generation and assembled in situ to
form a stable MAP scaffold. MAP scaffolds have been shown to improve tissue healing in both skin and brain through a
porosity-dependent reduction in wound inflammation and promotion of cell/tissue integration. We are focusing on
material improvements to counter three known difficulties for material-based treatment of diabetic wounds: abnormally
high immune activity, increased protease concentrations, and diminished new tissue generation. Specifically, we have
identified three MAP properties that we can independently modulate for instructive optimization: pore geometry (known
immunomodulatory parameter), degradability (premature material degradation results in loss pore-mediated effects), and
heterogeneous heparin “micro-islands” (a novel material-based strategy we have developed to improve intra-scaffold
angiogenesis). We hypothesize that investigating and optimizing each property individually will accelerate diabetic
wound closure and that the optimized properties can be combined synergistically.
We will evaluate and optimize each material property using the following characterization workflow: in vitro property
quantification (property-dependent), in vitro cell response (survival, proliferation, and migration), in vivo immune
response (analysis by FACS), in vivo material degradation (analysis by histology), and in vivo tissue healing/regeneration
(analysis by immunohistology). Our studies focus on the diabetic wound environment through use of dermal cell lines in
vitro and a diabetic mouse (db/db) splinted wound healing model. Each Aim of our approach isolates an individual
material property to simplify the investigation. For example, pore geometry impact is investigated using a single hydrogel
formulation and hydrogel formulation impact uses a single pore geometry (constant formulation and pore geometry taken
from our successful non-diabetic studies). If successful, this project will provide a better understanding of tissue response
to a new class of biomaterial (MAP scaffold) and produce an inexpensive and effective scaffold treatment option for
accelerating diabetic wound closure.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Spatially heterogeneous epidermal growth factor release from microporous annealed particle (MAP) hydrogel for improved wound closure.
微孔退火颗粒 (MAP) 水凝胶释放空间异质表皮生长因子,以改善伤口闭合。
DOI:
10.1039/d1tb00715g
发表时间:
2021-09-15
期刊:
Journal of materials chemistry. B
影响因子:
--
作者:
[Pruett L, Ellis R, McDermott M, Roosa C, Griffin D]
通讯作者:
Griffin D
DOI:
10.1021/acsbiomaterials.0c01580
发表时间:
2021-02-08
期刊:
ACS biomaterials science & engineering
影响因子:
5.8
作者:
[Pfaff BN, Pruett LJ, Cornell NJ, de Rutte J, Di Carlo D, Highley CB, Griffin DR]
通讯作者:
Griffin DR
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10460610
-
项目类别:
-
资助金额:$64.44万
-
财政年份:2021
-
负责人:Donald Richieri Griffin
-
依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10297936
-
项目类别:
-
资助金额:$64.44万
-
财政年份:2021
-
负责人:Donald Richieri Griffin
-
依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10657614
-
项目类别:
-
资助金额:$63.04万
-
财政年份:2021
-
负责人:Donald Richieri Griffin
-
依托单位:
VEGF Gradients in Porous Hydrogels for Therapeutic Angiogenesis
-
批准号:8992266
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2015
-
负责人:Donald Richieri Griffin
-
依托单位:
海外基金